Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
(MedPage Today) — The FDA on Tuesday approved mirdametinib (Gomekli) for adults and kids ages 2 and up with neurofibromatosis type 1 (NF1).Approval of the MEK inhibitor is specifically for patients who have symptomatic plexiform neurofibromas…
Source link
